Profile data is unavailable for this security.
About the company
Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
- Revenue in EUR (TTM)1.84bn
- Net income in EUR12.88m
- Incorporated1999
- Employees1.00k
- LocationMedios AGHeidestrasse 9BERLIN 10557GermanyDEU
- Phone+49 30 232566800
- Fax+49 30 232566801
- Websitehttps://medios.ag/
More ▼
Mergers & acquisitions
| Acquired company | ILM1X:GER since announced | Transaction value |
|---|---|---|
| Ceban Pharmaceuticals BV | -6.34% | 282.65m |
Data delayed at least 15 minutes, as of Nov 22 2024 09:26 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Celon Pharma SA | 48.27m | -10.47m | 322.37m | 566.00 | -- | 2.89 | 169.59 | 6.68 | -0.8908 | -0.8908 | 4.11 | 9.00 | 0.3592 | 2.21 | 5.21 | 400,898.70 | -7.79 | -2.24 | -9.03 | -2.57 | 70.12 | 70.71 | -21.69 | -7.79 | 2.27 | -64.27 | 0.0321 | -- | 11.29 | 11.57 | 28.40 | -- | -13.42 | -19.73 |
| Cutia Therapeutics | 26.20m | -69.09m | 324.37m | 360.00 | -- | 1.98 | -- | 12.38 | -1.85 | -1.85 | 0.7018 | 4.19 | 0.1206 | 2.31 | 6.93 | 716,808.00 | -31.81 | -- | -35.82 | -- | 50.33 | -- | -263.68 | -- | 4.82 | -- | 0.1818 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
| Euroapi SA | 971.30m | -287.30m | 326.73m | 3.67k | -- | 0.3661 | -- | 0.3364 | -3.04 | -3.04 | 10.29 | 9.34 | 0.5306 | 1.23 | 4.68 | 264,731.50 | -15.69 | -- | -23.68 | -- | 17.04 | -- | -29.58 | -- | 0.7027 | -- | 0.3464 | -- | 3.87 | -- | -1,164.67 | -- | -- | -- |
| Standard Chem & Pharm Co Ltd | 196.71m | 24.85m | 334.84m | 1.13k | 13.48 | 1.93 | 7.13 | 1.70 | 4.74 | 4.74 | 37.50 | 33.05 | 0.6066 | 2.39 | 6.00 | -- | 10.98 | 9.68 | 20.02 | 17.61 | 43.81 | 43.75 | 18.10 | 17.02 | 1.93 | -- | 0.0795 | 60.34 | 6.64 | 11.80 | 2.39 | 17.40 | 29.97 | 12.47 |
| Medios AG | 1.84bn | 12.88m | 335.66m | 1.00k | 24.71 | 0.6614 | 8.42 | 0.1823 | 0.5326 | 0.5326 | 76.07 | 19.90 | 2.39 | 23.11 | 12.28 | 3,576,214.00 | 1.67 | 3.40 | 2.36 | 4.07 | 7.19 | 6.05 | 0.699 | 1.01 | 0.7551 | 5.97 | 0.3174 | 0.00 | 10.80 | 40.34 | 2.62 | 34.17 | -7.11 | -- |
| Novoprotein Scientific Inc | 17.75m | -2.81m | 337.69m | 579.00 | -- | 1.19 | -- | 19.02 | -0.3031 | -0.3031 | 1.92 | 30.57 | 0.0592 | 0.5833 | 1.96 | 232,406.80 | -0.937 | -- | -0.959 | -- | 61.17 | -- | -15.82 | -- | 34.60 | -- | 0.0323 | -- | -42.09 | -- | -85.84 | -- | -- | -- |
| Ginwa Enterprise Group Inc | 76.71m | -2.05m | 338.27m | 553.00 | -- | 1.69 | -- | 4.41 | -0.0382 | -0.0382 | 1.58 | 4.07 | 0.2968 | 4.81 | 5.28 | 1,051,591.00 | -0.7916 | 0.3641 | -0.9515 | 0.4141 | 76.18 | 73.64 | -2.67 | 1.15 | 2.19 | 0.196 | 0.0431 | 124.25 | -2.41 | -5.37 | -228.19 | -- | 61.66 | -- |
| Amylyx Pharmaceuticals Inc | 187.58m | -247.71m | 339.65m | 384.00 | -- | 1.81 | -- | 1.81 | -3.82 | -3.82 | 2.87 | 2.86 | 0.5479 | 2.56 | 12.64 | 511,679.70 | -72.35 | -- | -84.00 | -- | 78.88 | -- | -132.05 | -- | 4.55 | -- | 0.00 | -- | 1,612.94 | -- | 124.84 | -- | -- | -- |
| SCI Pharmtech Inc | 41.44m | 14.20m | 343.44m | 241.00 | 24.55 | 2.16 | 16.70 | 8.29 | 3.99 | 3.99 | 13.98 | 45.36 | 0.2211 | 1.82 | 4.61 | -- | 7.58 | 6.90 | 8.56 | 8.26 | 27.11 | 38.18 | 34.26 | 19.85 | 1.68 | 9.22 | 0.1692 | 42.38 | 33.83 | -9.10 | -4.55 | -8.00 | 44.67 | -16.35 |
| Probi AB | 54.41m | 939.45k | 345.20m | 157.00 | 367.45 | 2.92 | 35.68 | 6.34 | 0.9552 | 0.9552 | 55.33 | 120.07 | 0.4049 | 3.24 | 7.14 | 3,939,931.00 | 0.6991 | 4.64 | 0.7409 | 4.98 | 33.18 | 42.04 | 1.73 | 9.83 | 4.83 | -- | 0.0561 | 21.42 | 1.52 | 0.7684 | -58.60 | -26.09 | 31.01 | -- |
Data as of Nov 22 2024. Currency figures normalised to Medios AG's reporting currency: Euro EUR
23.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Paladin Asset Management Investmentaktiengesellschaft TGVas of 29 Feb 2024 | 1.17m | 4.57% |
| SEB Investment Management AB (Denmark)as of 29 Feb 2024 | 1.12m | 4.39% |
| Allianz Global Investors GmbHas of 29 Jan 2024 | 700.14k | 2.75% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 639.40k | 2.51% |
| Cr�dit Mutuel Asset Management SAas of 29 Dec 2023 | 494.31k | 1.94% |
| Mandatum Life Sijoituspalvelut Oyas of 30 Jun 2024 | 487.87k | 1.91% |
| Oddo BHF Asset Management SASas of 31 Oct 2024 | 381.43k | 1.50% |
| DNCA Finance SAas of 31 Dec 2023 | 361.03k | 1.42% |
| Kreissparkasse Biberachas of 31 Jul 2024 | 293.99k | 1.15% |
| Skandinaviska Enskilda Banken AB (Denmark)as of 31 Oct 2024 | 291.14k | 1.14% |
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
